BetterLife Pharma Appoints LifeSci Advisors as Investor Relations Firm
BetterLife Pharma Inc. has retained LifeSci Advisors to manage its investor relations and corporate communications as it progresses its lead drug candidate, BETR-001.
Stocks · News reference
Better Home & Finance Holding Company reported additional cost-saving measures in its third weekly 'Better 2.0' scorecard, totaling $6.6 million in annualized savings for the week.
Reference Details
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
Keep reading
BetterLife Pharma Inc. has retained LifeSci Advisors to manage its investor relations and corporate communications as it progresses its lead drug candidate, BETR-001.
A class action lawsuit has been filed against Better Home & Finance Holding Company (NASDAQ: BETR) in the U.S. District Court for the Southern District of New York. The lawsuit alleges that the company made false and misleading statements regarding its conversion funnel and $1 billion monthly funded volume target, which was allegedly slowing due to macro factors. Investors who purchased Better Home securities between March 13, 2026 and May 7, 2026 can participate in the action, with a deadline of November 20, 2026 to apply as lead plaintiff.